Episodios

  • Managing Oral and Dental Complications in Cancer Treatment

    Managing Oral and Dental Complications in Cancer Treatment
    Jul 11 2024
    David Dean, DDS, MSD, DABOM, FDS RCSEd, Fred Hutchinson Cancer Center and University of Washington School of Dentistry, Seattle, WA Recorded on April 25, 2024 David Dean, DDS, MSD, DABOM, FDS RCSEd Director, Oral Medicine Fred Hutchinson Cancer Center Clinical Associate Professor University of Washington School of Dentistry Seattle, WA Join us, as Dr. David Dean from Fred Hutchinson Cancer Center and the University of Washington School of Dentistry uncovers essential aspects of oral health in cancer care, including symptoms that may indicate a blood cancer, common dental complications that arise from treatment, and insights into preventative care. Dr. Dean also addresses special considerations for patients with cancer needing dental care and strategies for healthcare providers to provide optimal support for patients navigating dental challenges. Tune in to learn more today!
    Más Menos
    30 m
  • Exploring Survivorship Needs of Older Adults

    Exploring Survivorship Needs of Older Adults
    Jul 8 2024
    Cesar Rodriguez, MD, Mount Sinai Hospital, New York, NY Recorded on April 16, 2024 Cesar Rodriguez, MD Associate Professor of Medicine, Tisch Cancer Institute Clinical Director, Multiple Myeloma Center of Excellence Mount Sinai Hospital New York, NY Join us for an insightful episode with Dr. Cesar Rodriguez from Mount Sinai Hospital as he discusses the healthcare provider’s role in survivorship care for older adults. Dr. Rodriguez explores the unique challenges of managing long-term and late effects of treatment and coordinating follow-up care. He also shares valuable perspectives on the impact of language and cultural considerations, along with the importance of caregiver support for older adult survivors. Listen in today! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.
    Más Menos
    34 m
  • Strategic Approaches to Pediatric and AYA Survivorship Care

    Strategic Approaches to Pediatric and AYA Survivorship Care
    Jun 20 2024
    Karen E. Effinger, MD, MS, Children’s Healthcare of Atlanta, Atlanta, GA Recorded on April 4, 2024 Karen E. Effinger, MD, MS Associate Professor of Pediatrics Emory University School of Medicine Co-Director, Survivor Program Aflac Cancer & Blood Disorders Center, Children’s Healthcare of Atlanta Atlanta, GA In this episode, Dr. Karen Effinger from Children’s Healthcare of Atlanta, provides a comprehensive overview into survivorship care for pediatric, adolescent, and young adult (AYA) patients. Dr. Effinger discusses long-term effects of treatment, importance of survivorship guidelines, survivorship care plans, and ongoing care management. She also addresses approaches to support survivors and their families to underscore the vital role in optimizing outcomes. Tune in today to hear valuable insights into supporting pediatric and AYA survivors! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.
    Más Menos
    29 m
  • Insights and Updates on Navigating the AML Landscape

    Insights and Updates on Navigating the AML Landscape
    Jun 7 2024
    Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX Recorded on March 28, 2024 Hagop M. Kantarjian, M.D. Professor and Chairman, Department of Leukemia Samsung Distinguished University Chair in Cancer Medicine MD Anderson Cancer Center, University of Texas Houston, TX Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center discusses the latest advancements and progress in treating Acute Myeloid Leukemia (AML). From understanding genetic mutations to exploring emerging treatment options, Dr. Kantarjian shares valuable insights into the forefront of AML research and care. Learn more today!
    Más Menos
    35 m
  • CAR T-cell Therapy in 2024

    CAR T-cell Therapy in 2024
    Apr 12 2024
    Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO Recorded on March 12, 2024 Michael Tees, MD, MPH Director, Lymphoma Program Lymphoma Executive Committee Member, Sarah Cannon Research Institute Associate Member, Colorado Blood Cancer Institute Denver, CO Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses Chimeric antigen receptor (CAR) T-cell therapy in 2024. Dr. Tees provides an overview of immunotherapy and approved indications, how to discuss treatment options with your patients, what to consider when referring patients for CAR T-cell therapy, how to prepare patients, and educating patients and caregivers about toxicity management. He also provides insight into the limitations of CAR-T therapy, as well as future directions. Tune in to this informative episode today to learn more! This episode is supported by Bristol Myers Squibb, Johnson & Johnson|Legend Biotech, Kite, a Gilead Company, and Novartis Pharmaceuticals Corporation.
    Más Menos
    29 m
  • Supporting Healthcare Professionals to Reduce Burnout

    Supporting Healthcare Professionals to Reduce Burnout
    Mar 14 2024
    Alfred Lee, MD, PhD, Yale University, New Haven, CT Recorded on February 22, 2024 Alfred Lee, MD, PhD Professor of Medicine, Yale School of Medicine Program Director, Hematology and Medical Oncology Fellowship Chief, Division of Classical Hematology, Yale Cancer Center Yale University New Haven, CT Join us for this important and engaging episode, as Dr. Alfred Lee from Yale University addresses stress and burnout in healthcare professionals. While reflecting on his personal experience, Dr. Lee discusses warning signs, symptoms, risk factors, and strategies and resources to help reduce and prevent burnout. Tune in today!
    Más Menos
    29 m
  • Creating a Roadmap for Adult Survivorship Care

    Creating a Roadmap for Adult Survivorship Care
    Jan 30 2024
    Meghna Ailawadhi, M.B.B.S., M.D., Mayo Clinic, Jacksonville, FL Recorded on December 7, 2023 Meghna Ailawadhi, M.B.B.S., M.D. Cancer Survivorship Consultant, Assistant Professor of Medicine Department of Hematology/Oncology Mayo Clinic Jacksonville, FL In this episode, Dr. Meghna Ailawadhi from the Mayo Clinic in Jacksonville, FL joins us for a conversation on survivorship care for adults. Dr. Ailawadhi discusses the importance of shared decision-making and coordination with primary care, including strategies to support adherence. She also provides an overview of disparities and challenges in survivorship care, as well as education and support resources for healthcare professionals and survivors. Learn more by listening today! This episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Merck & Co. Inc.
    Más Menos
    26 m
  • Highlights from attending the 2023 ASH Annual Meeting

    Highlights from attending the 2023 ASH Annual Meeting
    Jan 10 2024
    Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2023 Lee Greenberger, PhD Chief Scientific Officer and SVP The Leukemia & Lymphoma Society Rye Brook, NY Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to discuss highlights from the 65th American Society of Hematology (ASH) Annual Meeting in December 2023, including updates on blood cancer research, treatment, and clinical trials in leukemia, lymphoma, myeloma, MDS, and MPNs. Tune in to this informative update today!
    Más Menos
    32 m